ReviewViruses2024

EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes.

Nancy Law et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.